OFFICIAL PUBLICATION OF

by its subsidiary APPco

Time allows Regulation Impact Statement on codeine: PSA

Megan Haggan 19/11/2015

The Pharmaceutical Society of Australia has welcomed the deferral of a final decision on the possible rescheduling of codeine. PSA National President, Joe Demarte says that the extra time allowed by the deferral must be used to prepare a full Regulation Impact Statement on the proposal to reschedule codeine. Demarte says the PSA in its

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘Consumer confusion, pharmacist frustration’ if current system continues

I welcome Mark's move, at least someone talks about it. But like any push at the forefront, it comes with…

Benjamyn Sung

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Time allows Regulation Impact Statement on codeine: PSA

Previous Australia the 'lucky country' in antibiotic resistance

Next New antibiotic from MSD

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Australia the 'lucky country' in antibiotic resistance

Next New antibiotic from MSD

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.